The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(20S,22R)-6-beta,18-Diacetoxy-4-beta,5-beta-epoxy-14-alpha,17-beta,20-trihydroxy-1-oxowitha-2,24-dienolide ID: ALA4870660
PubChem CID: 164625239
Max Phase: Preclinical
Molecular Formula: C32H42O11
Molecular Weight: 602.68
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)OC[C@]12CC[C@H]3[C@@H](C[C@@H](OC(C)=O)[C@]45O[C@H]4C=CC(=O)[C@]35C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)C1CC(C)=C(C)C(=O)O1
Standard InChI: InChI=1S/C32H42O11/c1-16-13-24(42-26(36)17(16)2)28(6,37)31(39)12-11-30(38)21-14-25(41-19(4)34)32-23(43-32)8-7-22(35)27(32,5)20(21)9-10-29(30,31)15-40-18(3)33/h7-8,20-21,23-25,37-39H,9-15H2,1-6H3/t20-,21+,23-,24?,25+,27-,28-,29+,30+,31+,32+/m0/s1
Standard InChI Key: GZXKVSVWXNMPGL-OMKQIMHGSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
28.2315 -13.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0316 -13.9011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8193 -13.1000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4145 -16.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4145 -16.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1266 -15.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8387 -16.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2609 -16.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5510 -15.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2605 -16.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2774 -14.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5564 -14.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9869 -14.9297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9779 -15.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7566 -16.0138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2468 -15.3543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7710 -14.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8433 -13.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3873 -14.3659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1930 -14.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4606 -13.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9161 -12.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1039 -12.9635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1266 -14.9054 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8313 -15.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9815 -14.1011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2643 -13.6932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2590 -12.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5418 -12.4604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9708 -12.4511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9732 -16.5764 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5942 -14.6804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1822 -12.0228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2701 -13.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7360 -14.8269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5438 -16.5597 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
27.2523 -15.3305 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
26.5440 -17.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5416 -18.2106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8259 -18.6211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8236 -19.4461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1126 -18.2064 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8366 -16.9782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1301 -17.3786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8301 -17.7903 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5395 -17.9599 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
4 6 1 0
5 44 1 0
7 6 1 0
7 43 1 0
7 9 1 0
38 8 1 0
8 10 1 0
9 10 1 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
17 2 1 0
2 18 1 0
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
6 24 2 0
7 25 1 1
13 26 1 1
26 27 1 0
27 28 1 0
28 29 1 0
28 30 2 0
14 31 1 6
17 32 1 1
22 33 1 0
21 34 1 0
20 35 2 0
9 36 1 6
10 37 1 1
43 38 1 0
38 39 1 1
39 40 1 0
40 41 1 0
40 42 2 0
44 43 1 0
44 45 1 0
43 45 1 1
44 46 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 602.68Molecular Weight (Monoisotopic): 602.2727AlogP: 1.84#Rotatable Bonds: 5Polar Surface Area: 169.19Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.68CX Basic pKa: ┄CX LogP: 1.38CX LogD: 1.38Aromatic Rings: ┄Heavy Atoms: 43QED Weighted: 0.24Np Likeness Score: 3.00
References 1. Kithsiri Wijeratne EM, Xu YM, Liu MX, Inacio MC, Brooks AD, Tewary P, Sayers TJ, Gunatilaka AAL.. (2021) Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma., 84 (12.0): [PMID:34851111 ] [10.1021/acs.jnatprod.1c00724 ]